Dr David Musson
University of Auckland
Medicine
Our focus is on identifying novel anabolic factors and biomaterials that improve the healing of bone, tendon and soft-hard tissue interfaces, and combining these so that they can be used clinically by orthopaedic surgeons. I am also involved in basic research projects including understanding the biological reasons young patients are more susceptible to ACL re-rupture, understanding the molecular cross-talk between musculoskeletal tissues, and the genetic basis of rare bone diseases.